Janney Montgomery Scott LLC Novo Nordisk A S Transaction History

Janney Montgomery Scott LLC

  • $35.8 Billion
  • Q3 2024

A detailed history of Janney Montgomery Scott LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 264,567 shares of NVO stock, worth $28.3 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
264,567
Previous 268,584 1.5%
Holding current value
$28.3 Million
Previous $38.3 Million 17.83%
% of portfolio
0.09%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024
SELL
$119.07 - $145.42 $478,304 - $584,152
-4,017 Reduced 1.5%
264,567 $31.5 Million
Q2 2024

Jul 25, 2024
SELL
$122.71 - $146.91 $7.75 Million - $9.28 Million
-63,167 Reduced 19.04%
268,584 $38.3 Million
Q1 2024

May 01, 2024
BUY
$102.11 - $135.92 $2.71 Million - $3.61 Million
26,573 Added 8.71%
331,751 $42.6 Million
Q4 2023

Feb 07, 2024
BUY
$87.78 - $105.45 $1.35 Million - $1.62 Million
15,392 Added 5.31%
305,178 $31.6 Million
Q3 2023

Nov 08, 2023
BUY
$90.94 - $199.54 $13.9 Million - $30.4 Million
152,538 Added 111.14%
289,786 $26.4 Million
Q2 2023

Jul 26, 2023
BUY
$155.98 - $172.65 $1.94 Million - $2.15 Million
12,440 Added 9.97%
137,248 $22.2 Million
Q1 2023

Apr 28, 2023
SELL
$132.34 - $159.14 $1.76 Million - $2.11 Million
-13,281 Reduced 9.62%
124,808 $19.9 Million
Q4 2022

Feb 01, 2023
BUY
$102.55 - $135.33 $1.48 Million - $1.95 Million
14,407 Added 11.65%
138,089 $18.7 Million
Q3 2022

Oct 25, 2022
BUY
$95.28 - $116.93 $83,274 - $102,196
874 Added 0.71%
123,682 $12.3 Million
Q2 2022

Aug 03, 2022
SELL
$103.24 - $121.81 $330,058 - $389,426
-3,197 Reduced 2.54%
122,808 $13.5 Million
Q1 2022

May 04, 2022
BUY
$93.1 - $112.54 $171,210 - $206,961
1,839 Added 1.48%
126,005 $14 Million
Q4 2021

Jan 27, 2022
SELL
$95.88 - $117.08 $1.81 Million - $2.21 Million
-18,905 Reduced 13.21%
124,166 $13.9 Million
Q3 2021

Oct 29, 2021
BUY
$84.42 - $106.62 $598,453 - $755,829
7,089 Added 5.21%
143,071 $13.7 Million
Q2 2021

Jul 26, 2021
BUY
$67.66 - $84.76 $327,812 - $410,662
4,845 Added 3.69%
135,982 $11.4 Million
Q1 2021

Apr 27, 2021
SELL
$67.06 - $75.82 $561,292 - $634,613
-8,370 Reduced 6.0%
131,137 $8.84 Million
Q4 2020

Jan 25, 2021
BUY
$63.89 - $73.8 $1.1 Million - $1.27 Million
17,176 Added 14.04%
139,507 $9.75 Million
Q3 2020

Nov 06, 2020
BUY
$63.69 - $70.22 $5.05 Million - $5.57 Million
79,262 Added 184.03%
122,331 $8.49 Million
Q2 2020

Jul 23, 2020
SELL
$58.54 - $67.94 $110,640 - $128,406
-1,890 Reduced 4.2%
43,069 $2.82 Million
Q1 2020

Apr 30, 2020
SELL
$49.46 - $64.78 $1.99 Million - $2.61 Million
-40,313 Reduced 47.28%
44,959 $2.71 Million
Q4 2019

Jan 21, 2020
BUY
$49.86 - $58.26 $480,101 - $560,985
9,629 Added 12.73%
85,272 $4.94 Million
Q3 2019

Oct 29, 2019
BUY
$47.54 - $53.43 $1.73 Million - $1.94 Million
36,331 Added 92.42%
75,643 $3.91 Million
Q2 2019

Jul 29, 2019
SELL
$46.79 - $52.47 $138,779 - $155,626
-2,966 Reduced 7.02%
39,312 $2.01 Million
Q1 2019

Apr 30, 2019
SELL
$46.36 - $52.63 $381,125 - $432,671
-8,221 Reduced 16.28%
42,278 $2.21 Million
Q4 2018

Feb 01, 2019
BUY
$41.54 - $47.25 $241,887 - $275,136
5,823 Added 13.03%
50,499 $2.33 Million
Q3 2018

Nov 05, 2018
BUY
$46.76 - $51.24 $35,070 - $38,430
750 Added 1.71%
44,676 $2.11 Million
Q2 2018

Jul 24, 2018
SELL
$44.29 - $50.42 $124,322 - $141,528
-2,807 Reduced 6.01%
43,926 $2.03 Million
Q1 2018

Apr 19, 2018
BUY
$48.49 - $58.14 $126,849 - $152,094
2,616 Added 5.93%
46,733 $2.3 Million
Q4 2017

Feb 14, 2018
BUY
$47.53 - $53.73 $219,065 - $247,641
4,609 Added 11.67%
44,117 $2.37 Million
Q3 2017

Nov 15, 2017
BUY
$41.15 - $49.22 $1.63 Million - $1.94 Million
39,508
39,508 $1.9 Million

Others Institutions Holding NVO

# of Institutions
1,955
Shares Held
319M
Call Options Held
5.32M
Put Options Held
5.04M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $242B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email